Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|June 23, 2010
NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosaLaura Zamorano, Thomas M Reeve, Lehua Deng, et al.Environmental Microbiology|August 15, 2017
Sensing Mg2+ contributes to the resistance of Pseudomonas aeruginosa to complement-mediated opsonophagocytosisMohammad Qadi, Sofía Izquierdo-Rabassa, Margalida Mateu Borrás, et al.Frontiers in Microbiology|October 16, 2023
The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental researchElena Jordana-Lluch, Isabel Mª Barceló, María Escobar-Salom, et al.BMC Infectious Diseases|October 15, 2011
A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisitionCristina Suarez, Carmen Peña, Olga Arch, et al.The Journal of Antimicrobial Chemotherapy|July 14, 2010
Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamasesMaría Merino, Francisco J Pérez-Llarena, Frederic Kerff, et al.Frontiers in Microbiology|September 12, 2019
Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute InfectionsGabriel Torrens, María Escobar-Salom, Elisabet Pol-Pol, et al.Plos One|July 26, 2017
Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune systemGabriel Torrens, Marcelo Pérez-Gallego, Bartolomé Moya, et al.Antimicrobial Agents and Chemotherapy|February 5, 2014
Comparison of local features from two Spanish hospitals reveals common and specific traits at multiple levels of the molecular epidemiology of metallo-β-lactamase-producing Pseudomonas sppEsther Viedma, Vanesa Estepa, Carlos Juan, et al.BMJ Open Respiratory Research|October 7, 2021
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPDHanaa Shafiek, Javier Verdú, Amanda Iglesias, et al.Microbiology Spectrum|October 10, 2022
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosaIsabel M Barceló, Elena Jordana-Lluch, María Escobar-Salom, et al.Pageof 12